Cancer Treatment Centers of America® (CTCA) Phoenix is the first hospital in the western half of the U.S. and the first hospital in Arizona to utilize GI Genius – a powerful ally in the fight against colorectal cancer that employs artificial intelligence (AI) to help physicians detect polyps.
The GI Genius module uses advanced AI software to highlight suspicious polyps with a visual marker in real time—serving as the gastroenterologist’s ever-vigilant second observer with a sensitivity rate per lesion of 99.7%.1 Studies have shown that AI-assisted colonoscopy can increase polyp detection rates, and every 1% increase in adenoma detection rate reduces the risk of colorectal cancer by 3%.2,3 Colorectal cancer is the third most common form of cancer diagnosed in the U.S., with almost 150,000 new cases every year.
Trending
- Doctronic AI Appoints Dr. Byron Crowe as Chief Medical Officer to Lead Next Stage of Clinical Innovation (Business Wire)
- Evaluating benefit-to-burden ratios of the established and emerging colorectal cancer screening strategies (Journal of the National Cancer Institute)
- Evidence grows that gut microbes shape mental health, opening doors for new therapies (Medical Xpress)
- Doctors cancel telehealth appointments as Medicare coverage lapses (Roll Call)
- 10 Must-Read Posts in GI Oncology This Week (OncoDaily)
- California passes laws targeting PBMs, private equity (Healthcare Dive)
- Event: Future of GI: Modern Solutions for a Modern GI Practice (FoodMarble)
- AI could make it harder to establish blame for medical failings, experts say (The Guardian)
